Kakko, Johan

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Kakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 466

Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice

Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 140

Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence

Kakko, J., von Wachenfeldt, J., Svanborg, K. D., Lidström, J., Barr, C. S., & Heilig, M. (2008) · Biological Psychiatry

Opioid Use Disorder TreatmentStress Responses and Cortisol

Cited by 41

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice

Kakko, J., Gedeon, C., Sandell, M., Grelz, H., Birkemose, I., Clausen, T., Rúnarsdóttir, V., Simojoki, K., Littlewood, R., Alho, H., et al. (2018) · Substance Abuse Treatment Prevention and Policy

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 10